HEALTH
Liver Fat and Heart Rhythm: A Hidden Connection
Wed Apr 23 2025
The liver is often seen as the body's filter, but it also plays a role in heart health. Metabolic dysfunction-associated steatotic liver disease (MASLD) is a condition where fat builds up in the liver. It was once called nonalcoholic fatty liver disease. MASLD is not just a liver issue. It can affect the whole body, especially the heart. One major heart problem linked to MASLD is atrial fibrillation (AF). AF is a common heart rhythm disorder that can lead to serious health issues. So, understanding the link between MASLD and AF is crucial.
The connection between MASLD and AF is complex. Both conditions share some underlying processes. These include inflammation throughout the body, insulin resistance, oxidative stress, and the activation of the renin-angiotensin-aldosterone system. These processes can change the structure and electrical activity of the heart's upper chambers, making AF more likely in people with MASLD. Studies have shown that MASLD increases the risk of AF, especially in those with other metabolic issues like obesity and type 2 diabetes.
MASLD doesn't just increase the risk of AF. It can also affect how AF progresses and responds to treatment. This includes how safe blood thinners are, how well rhythm-control methods work, and the success of catheter ablation. This is why managing MASLD is so important. Treatments that target metabolic dysfunction, such as statins, certain blood pressure medications, and lifestyle changes, can help reduce the risk of both MASLD and AF. However, there's still a lot to learn. Researchers need to figure out the exact cause-and-effect relationship, how severe MASLD affects AF, and the best ways to treat both conditions together.
Future studies should focus on long-term research, understanding the mechanisms, and testing different treatments. This will help create more personalized and effective treatment plans. Incorporating MASLD screening into heart health assessments could lead to earlier detection and better outcomes for those at risk.
continue reading...
questions
How does the presence of MASLD independently influence the incidence of atrial fibrillation, beyond the effects of known metabolic comorbidities?
What specific pathophysiological mechanisms link MASLD to the development and progression of atrial fibrillation?
Are there hidden environmental factors causing both MASLD and atrial fibrillation that are being overlooked?
inspired by
actions
flag content